Asthma Preventive Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : January 2021 Pages : 168 Category: Medical Devices Report Code : HC0114574
Asthma Preventive Market by Type (Prednisolone,Sodium Cromolyn)Application (Adult, Children)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
Asthma PreventiveMarket has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.In order to be successful, asthma prophylaxis must be adopted over a period of time. However, these treatments are not necessary for the onset of the illness.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Abbot
- Pfizer
- Astrazeneca
- Novartis
- GSK
- Roche
- BoehringerIngelheim
- Merck
- Biotest AG
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Asthma Preventive Market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o Prednisolone
o Sodium Cromolyn
· Asthma Preventive Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Adult
· Asthma Preventive Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Abbot
o Pfizer
o Astrazeneca
o Novartis
o GSK
o Roche
o BoehringerIngelheim
o Merck
o Biotest AG
· Asthma Preventive Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Asthma Preventive Market, By Country
o U.S. Asthma Preventive Market
o Canada Asthma Preventive Market
o Mexico Asthma Preventive Market
o Europe
§ Europe Asthma Preventive Market, By Country
· Germany Asthma Preventive Market
o UK Asthma Preventive Market
o France Asthma Preventive Market
o RussiaAsthma Preventive Market
o Italy Asthma Preventive Market
o Rest of Europe Asthma Preventive Market
o Asia-Pacific
§ Asia-Pacific Asthma Preventive Market, By Country
o ChinaAsthma Preventive Market
o Japan Asthma Preventive Market
o South KoreaAsthma Preventive Market
o India Asthma Preventive Market
o Southeast AsiaAsthma Preventive Market
o Rest of Asia-Pacific Asthma Preventive Market
o South America
§ South AmericaAsthma Preventive Market
o Brazil Asthma Preventive Market
o ArgentinaAsthma Preventive Market
o ColumbiaAsthma Preventive Market
o Rest of South America Asthma Preventive Market
o Middle East and Africa
§ Middle East and AfricaAsthma Preventive Market
o Saudi ArabiaAsthma Preventive Market
o UAEAsthma Preventive Market
o EgyptAsthma Preventive Market
o NigeriaAsthma Preventive Market
o South Africa Asthma Preventive Market
o Rest of MEA Asthma Preventive Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Asthma Preventive Market, By Type
5.1. Introduction
5.2. Global Asthma Preventive Revenue and Market Share by Type (2017-2021)
5.2.1. Global Asthma Preventive Revenue and Revenue Share by Type (2017-2021)
5.3. Prednisolone
5.3.1. Global Prednisolone Revenue and Growth Rate (2017-2021)
5.4. Sodium Cromolyn
5.4.1. Global Sodium Cromolyn Revenue and Growth Rate (2017-2021)
6. Asthma Preventive Market, By Application
6.1. Introduction
6.2. Global Asthma Preventive Revenue and Market Share by Application (2017-2021)
6.2.1. Global Asthma Preventive Revenue and Revenue Share by Application (2017-2021)
6.3. Adult
6.3.1. Global Adult Revenue and Growth Rate (2017-2021)
6.4. Children
6.4.1. Global Children Revenue and Growth Rate (2017-2021)
7. Asthma Preventive Market, By Region
7.1. Introduction
7.2. Global Asthma Preventive Revenue and Market Share by Regions
7.2.1. Global Asthma Preventive Revenue by Regions (2017-2021)
7.3. North America Asthma Preventive by Countries
7.3.1. North America Asthma Preventive Revenue and Growth Rate (2017-2021)
7.3.2. North America Asthma Preventive Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Asthma Preventive by Countries
7.4.1. Europe Asthma Preventive Revenue and Growth Rate (2017-2021)
7.4.2. Europe Asthma Preventive Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Asthma Preventive by Countries
7.5.1. Asia-Pacific Asthma Preventive Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Asthma Preventive Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Asthma Preventive by Countries
7.6.1. South America Asthma Preventive Revenue and Growth Rate (2017-2021)
7.6.2. South America Asthma Preventive Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Asthma Preventive by Countries
7.7.1. Middle East and Africa Asthma Preventive Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Asthma Preventive Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Abbot
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Pfizer
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Astrazeneca
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Novartis
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. GSK
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Roche
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Boehringer Ingelheim
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Merck
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Biotest AG
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Asthma Preventive Market Forecast (2022-2027)
9.1. Global Asthma Preventive Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Asthma Preventive Market Forecast by Regions (2022-2027)
9.2.1. North America Asthma Preventive Market Forecast (2022-2027)
9.2.1.1. United States Asthma Preventive Market Forecast (2022-2027)
9.2.1.2. Canada Asthma Preventive Market Forecast (2022-2027)
9.2.1.3. Mexico Asthma Preventive Market Forecast (2022-2027)
9.2.2. Europe Asthma Preventive Market Forecast (2022-2027)
9.2.2.1. Germany Asthma Preventive Market Forecast (2022-2027)
9.2.2.2. France Asthma Preventive Market Forecast (2022-2027)
9.2.2.3. UK Asthma Preventive Market Forecast (2022-2027)
9.2.2.4. Russia Asthma Preventive Market Forecast (2022-2027)
9.2.2.5. Italy Asthma Preventive Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Asthma Preventive Market Forecast (2022-2027)
9.2.3. Asia-Pacific Asthma Preventive Market Forecast (2022-2027)
9.2.3.1. China Asthma Preventive Market Forecast (2022-2027)
9.2.3.2. Japan Asthma Preventive Market Forecast (2022-2027)
9.2.3.3. Korea Asthma Preventive Market Forecast (2022-2027)
9.2.3.4. India Asthma Preventive Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Asthma Preventive Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Asthma Preventive Market Forecast (2022-2027)
9.2.4. South America Asthma Preventive Market Forecast (2022-2027)
9.2.4.1. Brazil Asthma Preventive Market Forecast (2022-2027)
9.2.4.2. Argentina Asthma Preventive Market Forecast (2022-2027)
9.2.4.3. Columbia Asthma Preventive Market Forecast (2022-2027)
9.2.4.4. Rest of South America Asthma Preventive Market Forecast (2022-2027)
9.2.5. Middle East and Africa Asthma Preventive Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Asthma Preventive Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Asthma Preventive Market Forecast (2022-2027)
9.2.5.3. Egypt Asthma Preventive Market Forecast (2022-2027)
9.2.5.4. Nigeria Asthma Preventive Market Forecast (2022-2027)
9.2.5.5. South Africa Asthma Preventive Market Forecast (2022-2027)
9.2.5.6. Turkey Asthma Preventive Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Asthma Preventive Market Forecast (2022-2027)
9.3. Asthma Preventive Market Forecast by Type (2022-2027)
9.3.1. Asthma Preventive Forecast by Type (2022-2027)
9.3.2. Asthma Preventive Market Share Forecast by Type (2022-2027)
9.4. Asthma Preventive Market Forecast by Application (2022-2027)
9.4.1. Asthma Preventive Forecast by Application (2022-2027)
9.4.2. Asthma Preventive Market Share Forecast by Application (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Asthma Preventive Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Asthma Preventive Revenue and Revenue Share by Type (2017-2019)
Figure Global Prednisolone Revenue and Growth Rate (2017-2019)
Figure Global Sodium Cromolyn Revenue and Growth Rate (2017-2019)
Table Global Asthma Preventive Revenue and Revenue Share by Application (2017-2019)
Figure Global Adult Revenue and Growth Rate (2017-2019)
Figure Global Children Revenue and Growth Rate (2017-2019)
Table Global Asthma Preventive Revenue by Regions (2017-2019)
Figure North America Asthma Preventive Growth Rate (2017-2019)
Figure North America Asthma Preventive Revenue and Growth Rate (2017-2019)
Figure North America Asthma Preventive by Countries (2017-2019)
Figure North America Asthma Preventive Revenue (Million USD) by Countries (2017-2019)
Figure United States Asthma Preventive Growth Rate (2017-2019)
Figure United States Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Asthma Preventive Growth Rate (2017-2019)
Figure Canada Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Asthma Preventive Growth Rate (2017-2019)
Figure Mexico Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Asthma Preventive Growth Rate (2017-2019)
Figure Europe Asthma Preventive Revenue and Growth Rate (2017-2019)
Figure Europe Asthma Preventive by Countries (2017-2019)
Figure Europe Asthma Preventive Revenue (Million USD) by Countries (2017-2019)
Figure Germany Asthma Preventive Growth Rate (2017-2019)
Figure Germany Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Asthma Preventive Growth Rate (2017-2019)
Figure France Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Asthma Preventive Growth Rate (2017-2019)
Figure UK Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Asthma Preventive Growth Rate (2017-2019)
Figure Russia Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Asthma Preventive Growth Rate (2017-2019)
Figure Italy Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Asthma Preventive Growth Rate (2017-2019)
Figure Rest of Europe Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Asthma Preventive Growth Rate (2017-2019)
Figure Asia-Pacific Asthma Preventive Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Asthma Preventive by Countries (2017-2019)
Figure Asia-Pacific Asthma Preventive Revenue (Million USD) by Countries (2017-2019)
Figure China Asthma Preventive Growth Rate (2017-2019)
Figure China Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Asthma Preventive Growth Rate (2017-2019)
Figure Japan Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Asthma Preventive Growth Rate (2017-2019)
Figure Korea Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Asthma Preventive Growth Rate (2017-2019)
Figure India Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Asthma Preventive Growth Rate (2017-2019)
Figure Southeast Asia Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Asthma Preventive Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Asthma Preventive Growth Rate (2017-2019)
Figure South America Asthma Preventive Revenue and Growth Rate (2017-2019)
Figure South America Asthma Preventive by Countries (2017-2019)
Figure South America Asthma Preventive Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Asthma Preventive Growth Rate (2017-2019)
Figure Brazil Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Asthma Preventive Growth Rate (2017-2019)
Figure Argentina Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Asthma Preventive Growth Rate (2017-2019)
Figure Columbia Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Asthma Preventive Growth Rate (2017-2019)
Figure Rest of South America Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Asthma Preventive Growth Rate (2017-2019)
Figure Middle East and Africa Asthma Preventive Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Asthma Preventive by Countries (2017-2019)
Figure Middle East and Africa Asthma Preventive Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Asthma Preventive Growth Rate (2017-2019)
Figure Saudi Arabia Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Asthma Preventive Growth Rate (2017-2019)
Figure United Arab Emirates Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Asthma Preventive Growth Rate (2017-2019)
Figure Egypt Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Asthma Preventive Growth Rate (2017-2019)
Figure Nigeria Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Asthma Preventive Growth Rate (2017-2019)
Figure South Africa Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Asthma Preventive Growth Rate (2017-2019)
Figure Turkey Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Asthma Preventive Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Asthma Preventive Revenue (Millions USD) and Growth Rate (2017-2019)
Table Abbot Asthma Preventive Financial Overview
Table Pfizer Asthma Preventive Financial Overview
Table Astrazeneca Asthma Preventive Financial Overview
Table Novartis Asthma Preventive Financial Overview
Table GSK Asthma Preventive Financial Overview
Table Roche Asthma Preventive Financial Overview
Table Boehringer Ingelheim Asthma Preventive Financial Overview
Table Merck Asthma Preventive Financial Overview
Table Biotest AG Asthma Preventive Financial Overview
Figure Global Asthma Preventive Revenue (Millions USD) and Growth Rate (2019-2027)
Table Asthma Preventive Market Forecast by Regions (2019-2027)
Figure North America Asthma Preventive Market Forecast (2019-2027)
Figure United States Asthma Preventive Market Forecast (2019-2027)
Figure Canada Asthma Preventive Market Forecast (2019-2027)
Figure Mexico Asthma Preventive Market Forecast (2019-2027)
Figure Europe Asthma Preventive Market Forecast (2019-2027)
Figure Germany Asthma Preventive Market Forecast (2019-2027)
Figure France Asthma Preventive Market Forecast (2019-2027)
Figure UK Asthma Preventive Market Forecast (2019-2027)
Figure Russia Asthma Preventive Market Forecast (2019-2027)
Figure Italy Asthma Preventive Market Forecast (2019-2027)
Figure Rest of Europe Asthma Preventive Market Forecast (2019-2027)
Figure Asia-Pacific Asthma Preventive Market Forecast (2019-2027)
Figure China Asthma Preventive Market Forecast (2019-2027)
Figure Japan Asthma Preventive Market Forecast (2019-2027)
Figure Korea Asthma Preventive Market Forecast (2019-2027)
Figure India Asthma Preventive Market Forecast (2019-2027)
Figure Southeast Asia Asthma Preventive Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Asthma Preventive Market Forecast (2019-2027)
Figure South America Asthma Preventive Market Forecast (2019-2027)
Figure Brazil Asthma Preventive Market Forecast (2019-2027)
Figure Argentina Asthma Preventive Market Forecast (2019-2027)
Figure Columbia Asthma Preventive Market Forecast (2019-2027)
Figure Rest of South America Asthma Preventive Market Forecast (2019-2027)
Figure Middle East and Africa Asthma Preventive Market Forecast (2019-2027)
Figure Saudi Arabia Asthma Preventive Market Forecast (2019-2027)
Figure United Arab Emirates Asthma Preventive Market Forecast (2019-2027)
Figure Egypt Asthma Preventive Market Forecast (2019-2027)
Figure Nigeria Asthma Preventive Market Forecast (2019-2027)
Figure South Africa Asthma Preventive Market Forecast (2019-2027)
Figure Turkey Asthma Preventive Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Asthma Preventive Market Forecast (2019-2027)
Figure Global Asthma Preventive Forecast by Type (2019-2027)
Figure Global Asthma Preventive Market Share Forecast by Type (2019-2027)
Figure Global Asthma Preventive Forecast by Type (2019-2027)
Figure Global Asthma Preventive Forecast by Application (2019-2027)
Figure Global Asthma Preventive Market Share Forecast by Application (2019-2027)
Figure Global Asthma Preventive Forecast by Application (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|